0000929638-21-000926.txt : 20210727 0000929638-21-000926.hdr.sgml : 20210727 20210727150633 ACCESSION NUMBER: 0000929638-21-000926 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210727 DATE AS OF CHANGE: 20210727 EFFECTIVENESS DATE: 20210727 FILER: COMPANY DATA: COMPANY CONFORMED NAME: STRAND THERAPEUTICS INC CENTRAL INDEX KEY: 0001778475 IRS NUMBER: 824027324 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-407917 FILM NUMBER: 211117689 BUSINESS ADDRESS: STREET 1: 237 PUTNAM AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 309-360-9875 MAIL ADDRESS: STREET 1: 237 PUTNAM AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001778475 STRAND THERAPEUTICS INC 237 PUTNAM AVENUE CAMBRIDGE MA MASSACHUSETTS 02139 309-360-9875 DELAWARE None None Corporation true 2017 Jacob Becraft c/o Strand Therapeutics 237 Putnam Avenue Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Promoter Mr. Becraft is the Co-Founder and Chief Executive Officer of the Issuer. Tasuku Kitada c/o Strand Therapeutics 237 Putnam Avenue Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Promoter Dr. Kitada is a Co-Founder, the President and Secretary of the Issuer. Jory Bell c/o Strand Therapeutics 237 Putnam Avenue Cambridge MA MASSACHUSETTS 02139 Director Samta Jacob Kundu c/o Strand Therapeutics 237 Putnam Avenue Cambridge MA MASSACHUSETTS 02139 Executive Officer Ms. Kundu is the Chief Operating Officer of the Issuer. Biotechnology Decline to Disclose 06b false 2021-05-28 false true true Series A and A-1 Preferred Stock false 0 52143967 52143967 0 false 13 0 0 0 false STRAND THERAPEUTICS INC /s/ Jacob Becraft Jacob Becraft Chief Executive Officer of the Issuer 2021-07-27